SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Esperion Therapeutics - ESPR
An SI Board Since December 2013
Posts SubjectMarks Bans Symbol
0 1 0 ESPR
Emcee:  N. Dixon Type:  Moderated

Esperion Therapeutics

Esperion is a biopharmaceutical company focused on the research, development and commercialization of potential therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol (LDL-C) and other cardiometabolic risk factors.




Discussion Board for Esperion Therapeutics - ESPR


SI Market Page - ESPR
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):